Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease. (1st December 2020)

• Record Type: Journal Article
• Authors: Krishnaprasad, Krupa; Walsh, Alissa; Begun, Jakob; Bell, Sally; Carter, David; Grafton, Rachel; Sechi, Alexandra; Sewell, Karen; McMahon, Anna; Connor, Susan; Radford-Smith, Graham; Andrews, Jane M.
• Is Part Of: Scandinavian journal of gastroenterology. Volume 55:Number 12(2020)
• Page Start: 1419
• Page End: 1426
• Publication Date: 2020-12-01
• Subjects: Quality of care -- eHealth -- telemedicine -- inflammatory bowel disease -- clinical quality registry -- patient reported outcomes; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; 616.33
• DOI: 10.1080/00365521.2020.1839960
• Languages: English
• ISSNs: 0036-5521

Abstract

Abstract: Background: Adherence to evidence-based management is variable in inflammatory bowel disease (IBD), which leads to worse patient outcomes and higher healthcare utilization. Solutions include electronic systems to enhance care, but these have often been limited by lack of clinician design input, poor usability, and low perceived value. A cloud-based IBD-specific clinical management software – 'Crohn's Colitis Care' (CCCare) was developed by Australia and New Zealand Inflammatory Bowel Disease Consortium clinicians and software developers to improve this. Methods: CCCare captures patient-reported disease activity and medical assessment, medication monitoring, cancer screening, preventative health, and facilitates communication with the IBD team and referring doctor. De-identified longitudinal data are stored separately in a clinical quality registry for research. CCCare was tested for feasibility and usability in routine clinical settings at two large Australian hospitals. Users' experience was evaluated with System Usability Scale (SUS). Value to clinicians and patients was assessed by qualitative feedback. Security was assessed by penetration testing. Results: Users ( n = 13; doctors, nurses, patients) reported good usability and learnability (mean SUS score 75 (range 50–95), sub-scores were 77 (50–94) and 68 (38–100), respectively). Patients reported better communication with clinical team and greater ability to track disease. Clinicians highlighted structured management plans, medication adherence, and centralised data repository as positive features. Penetration testing was passed successfully. Conclusions: Initial evaluation demonstrates CCCare is usable, secure, and valued in clinical use. It is designed to measure outcomes of clinical care, including efficacy, quality, cost, and complications for individuals, and to audit these at hospital and national level.